SCHEMBL3849285

SCHEMBL3849285

O=Cc1ccc(-c2ncnc3ccc(Br)cc23)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
HTT P42858 8/20 0.40
LMNA P02545 5/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
MTOR P42345 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
MAPT P10636 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALK Q9UM73 1/20 0.37
GLA P06280 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CYP2A6 P11509 2/20 0.36
CHEK1 O14757 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847683 0.77 RPS6KB2 (0.50) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3845623 0.76 SMN1; SMN2 (0.44) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3847128 0.76 SMN1; SMN2 (0.44) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3851528 0.76 SMN1; SMN2 (0.47) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3846257 0.76 SMN1; SMN2 (0.46) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3849639 0.74 MAPT (0.42) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3846909 0.74 SMN1; SMN2 (0.41) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL3845271 0.73 TSHR (0.46) SMN1; SMN2HTTLMNAALDH1A1MAPT
SCHEMBL13874658 0.73 IRAK4 (0.36)
SCHEMBL3846109 0.73 HTT (0.45) SMN1; SMN2HTTLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed